German Biotech BioNTech Locks in $270M Series A Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace You Might Also Like Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran December 14, 2017 Surprising Departure: Celgene President and COO "Retiring" in the Summer February 23, 2017 A Double KEiBA Win For Bedfont Scientific Totals 4 Business Awards This Year June 29, 2017